Palisade Bio presents preclinical data of PALI-2108
Palisade Bio (PALI) announced the presentation of positive preclinical data from PALI-2108, an orally administered, colon-specific ...
pharmaphorum16h
Pfizer’s Velsipity heading for NHS use in ulcerative colitis
Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizer’s once-daily oral therapy Velsipity, after NICE recommended its use by the NHS. The new ...